The Development of a Magnesium-Releasing and Long-Term Mechanically Stable Calcium Phosphate Bone Cement Possessing Osteogenic and Immunomodulation Effects for Promoting Bone Fracture Regeneration
Open Access
- 11 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 9, 803723
Abstract
Bone grafts are commonly used for the treatment of critical sized bone defects. Since the supply of autologous bone is insufficient, allogeneic bone grafts have been used most of the time. However, the poor osteogenic property of allogeneic bone grafts after pretreatment results in delayed union, non-union, or even occasional deformity. Calcium phosphate cement (CPC) is one of the most promising bone filling materials due to its good biocompatibility and similar chemical components as natural bone. However, clinical applications of CPC were hampered by limited osteogenic effects, undesired immune response which results in resorption, and poor mechanical stability in vivo. Magnesium (Mg) has been proven to trigger bone regeneration through modulating cell behaviors of mesenchymal stem cells and macrophages significantly. Unfortunately, the degradation raters of pure Mg and Mg oxide are extremely fast, resulting in early collapse of Mg contained CPC. In this study, we developed a novel magnesium contained calcium phosphate bone cement (Mg-CPC), possessing long-term mechanical stability and osteogenic effects through sustained release of Mg. Furthermore, in vitro studies showed that Mg-CPC had no cytotoxic effects on hBMMSCs and macrophage RAW 264.7, and could enhance the osteogenic differentiation as determined by alkaline phosphate (ALP) activity and calcium nodule staining, as well as suppress the inflammatory as determined by expression of anti-inflammatory cytokine IL-1RA. We also found that Mg-CPC promoted new bone formation and bone maturation in vivo. These results suggest that Mg-CPC should be a good substitute material for bone grafts in clinical use.Keywords
Funding Information
- National Natural Science Foundation of China (81802959)
- Basic and Applied Basic Research Foundation of Guangdong Province (2018A030313888 2021A1515010191)
- Shenzhen Science and Technology Innovation Program (JSGG20180507183242702 JCYJ20200109150420892)
- Sanming Project of Medicine in Shenzen Municipality (SZSM201612055)
This publication has 46 references indexed in Scilit:
- Molecular mechanics of mineralized collagen fibrils in boneNature Communications, 2013
- An effective approach by a chelate reaction in optimizing the setting process of strontium‐incorporated calcium phosphate bone cementJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2012
- Immune responses to implants – A review of the implications for the design of immunomodulatory biomaterialsBiomaterials, 2011
- Osteogenic Media and rhBMP-2-Induced Differentiation of Umbilical Cord Mesenchymal Stem Cells Encapsulated in Alginate Microbeads and Integrated in an Injectable Calcium Phosphate-Chitosan Fibrous ScaffoldTissue Engineering Part A, 2011
- A biodegradable polymer-based coating to control the performance of magnesium alloy orthopaedic implantsBiomaterials, 2010
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Treatment of Peri‐Implant Defects With Combination Growth Factor CementJournal of Periodontology, 2000
- Complications of Iliac Crest Bone Graft HarvestingClinical Orthopaedics and Related Research, 1996
- Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.Journal of Experimental Medicine, 1992